{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:58:22Z","timestamp":1767772702114,"version":"3.40.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:p>Research suggests that cathepsins, due to their extensive mechanisms of action, may play a crucial role in cardiomyopathies. However, further studies are necessary to establish causality. This study aims to investigate the causal relationship between cathepsins and various types of cardiomyopathies. This study investigated causal associations between 9 cathepsins and cardiomyopathies, including their subtypes: hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy, and restrictive cardiomyopathy, using pooled data from genome-wide association studies. The analyses employed inverse variance weighted (IVW), Mendelian randomization (MR)-Egger, and weighted median methods for univariable MR, reverse MR, and multivariable MR to estimate causality. For sensitivity analyses, we applied Cochran Q test, MR-PRESSO, MR-Egger intercept test, and the leave-one-out method to ensure the robustness and reliability of our findings. Univariable MR analyses indicated that elevated levels of cathepsin E were associated with an increased risk of overall cardiomyopathy (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.045, odds ratio [OR]\u2005=\u20051.078, 95% confidence interval [CI]\u2005=\u20051.002\u20131.160). Conversely, higher levels of cathepsin B were linked to a reduced risk of HCM (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.037, OR\u2005=\u20050.856, 95% CI\u2005=\u20050.740\u20130.990), and higher cathepsin O levels were causally related to a reduced risk of HCM (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.04, OR\u2005=\u20050.810, 95% CI\u2005=\u20050.662\u20130.991). Reverse MR analyses indicated that a higher risk of HCM was causally related to increased levels of cathepsin E (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.038, OR\u2005=\u20051.024, 95% CI\u2005=\u20051.001\u20131.047). Multivariable MR analyses showed that increased cathepsin E levels still correlated with increased overall cardiomyopathy, even after the addition of other types of cathepsins (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0165, OR\u2005=\u20051.005, 95% CI\u2005=\u20051.0176\u20131.1901), while cathepsin O levels remained causally related to a reduced risk of HCM (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0053, OR\u2005=\u20050.7183, 95% CI\u2005=\u20050.5692\u20130.9065). Cathepsin L2 was also found to be associated with an increased risk of restrictive cardiomyopathy (IVW: <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0374, OR\u2005=\u20052.1337, 95% CI\u2005=\u20051.0450\u20134.3565). This study demonstrates the causal relationship between cathepsins E, B, L2, O and the development of cardiomyopathy. The findings may be crucial for early diagnosis, prognosis prediction, molecular classification, and identifying potential therapeutic targets for cardiomyopathy.<\/jats:p>","DOI":"10.1097\/md.0000000000040974","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:03:04Z","timestamp":1734724984000},"page":"e40974","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between cathepsins and cardiomyopathy: A Mendelian randomization study"],"prefix":"10.1097","volume":"103","author":[{"given":"Qiuyun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gusu School, Nanjing Medical University, The First People\u2019s Hospital of Kunshan, Kunshan, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5118-9819","authenticated-orcid":false,"given":"Zongliang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China"},{"name":"Department of Cardiology, Gusu School, Nanjing Medical University, The First People\u2019s Hospital of Kunshan, Kunshan, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/erm.10.13","article-title":"Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.","volume":"10","author":"Callis","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2021-320181","article-title":"Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.","volume":"108","author":"Brownrigg","year":"2022","journal-title":"Heart"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","article-title":"Cathepsins: proteases that are vital for survival but can also be fatal.","volume":"105","author":"Patel","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI42918","article-title":"Specialized roles for cysteine cathepsins in health and disease.","volume":"120","author":"Reiser","year":"2010","journal-title":"J Clin Invest"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bcp.2008.07.041","article-title":"Cathepsins: key modulators of cell death and inflammatory responses.","volume":"76","author":"Conus","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials.","volume":"15","author":"Liu","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11010-016-2924-6","article-title":"Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy.","volume":"428","author":"Mehra","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacbts.2019.01.008","article-title":"Cathepsin A mediates ventricular remote remodeling and atrial cardiomyopathy in rats with ventricular ischemia\/reperfusion.","volume":"4","author":"Hohl","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12967-016-0907-8","article-title":"Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.","volume":"14","author":"Petrera","year":"2016","journal-title":"J Transl Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s12967-023-04567-9","article-title":"Unfolded protein response pathways in stroke patients: a comprehensive landscape assessed through machine learning algorithms and experimental verification.","volume":"21","author":"Yu","year":"2023","journal-title":"J Transl Med"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.7150\/jca.93376","article-title":"Mendelian randomization validates the immune landscape mediated by aggrephagy in esophageal squamous cell carcinoma patients from the perspectives of multi-omics.","volume":"15","author":"Yu","year":"2024","journal-title":"J Cancer"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10654-020-00622-7","article-title":"Mendel\u2019s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues.","volume":"35","author":"Davey Smith","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","article-title":"SNiPA: an interactive, genetic variant-centered annotation browser.","volume":"31","author":"Arnold","year":"2015","journal-title":"Bioinformatics"},{"key":"R18-20250503","first-page":"7141767","article-title":"Utilising network pharmacology to explore underlying mechanism of Astragalus membranaceus in improving sepsis-induced inflammatory response by regulating the balance of I\u03baB\u03b1 and NF-\u03baB in rats.","volume":"2022","author":"Yu","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"780133","DOI":"10.3389\/fendo.2022.780133","article-title":"Genetically predicted causality of 28 gut microbiome families and type 2 diabetes mellitus risk.","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization.","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"140360","DOI":"10.1016\/j.bbapap.2020.140360","article-title":"Cysteinyl cathepsins in cardiovascular diseases.","volume":"1868","author":"Zhang","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejheart.2005.09.004","article-title":"Enhanced myocardial cathepsin B expression in patients with dilated cardiomyopathy.","volume":"8","author":"Ge","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"H1143","DOI":"10.1152\/ajpheart.00601.2014","article-title":"Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-\u03b1\/ASK1\/JNK pathway.","volume":"308","author":"Wu","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4613-0335-0_35","article-title":"Cathepsin B expression in human tumors.","volume":"389","author":"Berquin","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/gast.1997.v113.pm9352877","article-title":"Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes.","volume":"113","author":"Roberts","year":"1997","journal-title":"Gastroenterology"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"12806","DOI":"10.1074\/jbc.275.17.12806","article-title":"Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells.","volume":"275","author":"Mai","year":"2000","journal-title":"J Biol Chem"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1476-5586(03)80035-0","article-title":"Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells.","volume":"5","author":"Cavallo-Medved","year":"2003","journal-title":"Neoplasia"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1074\/jbc.M113.542407","article-title":"Regulation of TGF-\u03b21-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C.","volume":"289","author":"Kasabova","year":"2014","journal-title":"J Biol Chem"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"12488","DOI":"10.1523\/JNEUROSCI.1599-15.2015","article-title":"The critical role of proteolytic relay through cathepsins B and E in the phenotypic change of microglia\/macrophage.","volume":"35","author":"Ni","year":"2015","journal-title":"J Neurosci"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"7894247","DOI":"10.1155\/2016\/7894247","article-title":"Cathepsin B regulates collagen expression by fibroblasts via prolonging TLR2\/NF-\u03baB activation.","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"206039","DOI":"10.1155\/2013\/206039","article-title":"Danger signals in the initiation of the inflammatory response after myocardial infarction.","volume":"2013","author":"de Haan","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","article-title":"Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication.","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI181","article-title":"Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.","volume":"102","author":"Sukhova","year":"1998","journal-title":"J Clin Invest"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy.","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2021.02.040","article-title":"Oxidative stress in cardiac hypertrophy: from molecular mechanisms to novel therapeutic targets.","volume":"166","author":"Ramachandra","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers.","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"1348310","DOI":"10.3389\/fendo.2024.1348310","article-title":"Association between cathepsins and benign prostate diseases: a bidirectional two-sample Mendelian randomization study.","volume":"15","author":"Cao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2007.12.163","article-title":"Cathepsin E: a mini review.","volume":"367","author":"Zaidi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/ehf2.14826","article-title":"Genetic insights into the role of cathepsins in cardiovascular diseases: a Mendelian randomization study.","volume":"11","author":"Zeng","year":"2024","journal-title":"ESC Heart Fail"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/978-3-031-44087-8_62","article-title":"Clinical presentation and therapy of cardiomyopathies.","volume":"1441","author":"Haas","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"107347","DOI":"10.1016\/j.jbc.2024.107347","article-title":"Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis.","volume":"300","author":"Radisky","year":"2024","journal-title":"J Biol Chem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:29:27Z","timestamp":1746318567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":51,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040974","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}